A Clinical Study to Evaluate the Sensitizing Potential of LEO 43204 Gel

Clinical trial NCT02650505 · COMPLETED

Trial details

NCT number: NCT02650505
Sponsor: LEO Pharma
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Actinic Keratosis

Start date: 2016-02-01
Primary completion: 2016-06-01
Enrollment: 233

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.